Benitec Biopharma Inc. (BNTC) Social Stream

Benitec Biopharma Inc. (BNTC): $0.79

-0.06 (-7.39%)

POWR Rating

Component Grades













Add BNTC to Watchlist
Sign Up

Industry: Biotech


of 504

in industry

Benitec Biopharma Inc (BNTC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Benitec Biopharma Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-17 1 $10 $10 $10 $2.18 358.72%

Price Target Last Issued February 17, 2022

BNTC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Benitec Biopharma Inc's number of analysts covering the stock is greater than practically none of them.
  • In terms of how Benitec Biopharma Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than just about 100% of that group.
  • In terms of how Benitec Biopharma Inc fares relative to Healthcare stocks, note that its average analyst price target is greater than 15.2% of that group.
  • In the context of Healthcare stocks, Benitec Biopharma Inc's upside potential (average analyst target price relative to current price) is greater than 76.54% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Benitec Biopharma Inc are VIGL, VECT, and SMFL.

Make investment decisions regarding BNTC using the data that counts. Try POWR Ratings for free.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.3993 seconds.